The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M-tuberculosis-infected guinea pigs

被引:136
作者
Brandt, L
Skeiky, YAW
Alderson, MR
Lobet, Y
Dalemans, W
Turner, OC
Basaraba, RJ
Izzo, AA
Lasco, TM
Chapman, PL
Reed, SG
Orme, IM [1 ]
机构
[1] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA
[3] Corixa Corp, Seattle, WA USA
[4] GlaxoSmithKline Biol, Rixensart, Belgium
关键词
D O I
10.1128/IAI.72.11.6622-6632.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A tuberculosis vaccine candidate consisting of a 72-kDa polyprotein or fusion protein based upon the Mtb32 and Mtb39 antigens of Mycobacterium tuberculosis and designated Mtb72F was tested for its protective capacity as a potential adjunct to the Mycobacterium bovis BCG vaccine in the mouse and guinea pig models of this disease. Formulation of recombinant Mtb72F (rMtb72F) in an AS02A adjuvant enhanced the Th1 response to BCG in mice but did not further reduce the bacterial load in the lungs after aerosol challenge infection. In the more stringent guinea pig disease model, rMtb72F delivered by coadministration with BCG vaccination significantly improved the survival of these animals compared to BCG alone, with some animals still alive and healthy in their appearance at >100 weeks post-aerosol challenge. A similar trend was observed with guinea pigs in which BCG vaccination was boosted by DNA vaccination, although this increase was not statistically significant due to excellent protection conferred by BCG alone. Histological examination of the lungs of test animals indicated that while BCG controls eventually died from overwhelming lung consolidation, the majority of guinea pigs receiving BCG mixed with rMtb72F or boosted twice with Mtb72F DNA had mostly clear lungs with minimal granulomatous lesions. Lesions were still prominent in guinea pigs receiving BCG and the Mtb72F DNA boost, but there was considerable evidence of lesion healing and airway remodeling and reestablishment. These data support the hypothesis that the coadministration or boosting of BCG vaccination with Mtb72F may limit the lung consolidation seen with BCG alone and may promote lesion resolution and healing. Collectively, these data suggest that enhancing BCG is a valid vaccination strategy for tuberculosis that is worthy of clinical evaluation.
引用
收藏
页码:6622 / 6632
页数:11
相关论文
共 24 条
  • [1] Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
    Baldwin, SL
    D'Souza, C
    Roberts, AD
    Kelly, BP
    Frank, AA
    Lui, MA
    Ulmer, JB
    Huygen, K
    McMurray, DM
    Orme, IM
    [J]. INFECTION AND IMMUNITY, 1998, 66 (06) : 2951 - 2959
  • [2] Comparative genomics of BCG vaccines by whole-genome DNA microarray
    Behr, MA
    Wilson, MA
    Gill, WP
    Salamon, H
    Schoolnik, GK
    Rane, S
    Small, PM
    [J]. SCIENCE, 1999, 284 (5419) : 1520 - 1523
  • [3] A historical and molecular phylogeny of BCG strains
    Behr, MA
    Small, PM
    [J]. VACCINE, 1999, 17 (7-8) : 915 - 922
  • [4] Has BCG attenuated to impotence?
    Behr, MA
    Small, PM
    [J]. NATURE, 1997, 389 (6647) : 133 - 134
  • [5] TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER
    BLOOM, BR
    MURRAY, CJL
    [J]. SCIENCE, 1992, 257 (5073) : 1055 - 1064
  • [6] Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
    Bojang, KA
    Milligan, PJM
    Pinder, M
    Vigneron, L
    Alloueche, A
    Kester, KE
    Ballou, WR
    Conway, DJ
    Reece, WHH
    Gothard, P
    Yamuah, L
    Delchambre, M
    Voss, G
    Greenwood, BM
    Hill, A
    McAdam, KPWJ
    Tornieporth, N
    Cohen, JD
    Doherty, T
    [J]. LANCET, 2001, 358 (9297) : 1927 - 1934
  • [7] Improving vaccines against tuberculosis
    Britton, WJ
    Palendira, U
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (01) : 34 - 45
  • [8] Boosting vaccine for tuberculosis
    Brooks, JV
    Frank, AA
    Keen, MA
    Bellisle, JT
    Orme, IM
    [J]. INFECTION AND IMMUNITY, 2001, 69 (04) : 2714 - 2717
  • [9] EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE
    COLDITZ, GA
    BREWER, TF
    BERKEY, CS
    WILSON, ME
    BURDICK, E
    FINEBERG, HV
    MOSTELLER, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09): : 698 - 702
  • [10] Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country
    Dye, C
    Scheele, S
    Dolin, P
    Pathania, V
    Raviglione, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 677 - 686